Format

Send to

Choose Destination
Can J Clin Pharmacol. 2008 Summer;15(2):e344-66. Epub 2008 Sep 5.

Development of Canadian screening tools for fetal alcohol spectrum disorder.

Author information

1
The Motherisk Program, Division of Clinical Pharmacology & Toxicology, The Hospital for Sick Children, Toronto, Ontario.

Abstract

BACKGROUND:

Fetal alcohol spectrum disorder (FASD) is the most common cause of neurobehavioural handicap in North America. Screening for FASD may facilitate diagnosis and hence management of these children. We present a variety of screening tools for the identification of children at risk for FASD.

METHODS:

We critically reviewed and evaluated published and practiced methods for their potential of screening suspected cases, their epidemiological characteristics (sensitivity, specificity, positive and negative predictive values) [Phase I], as well as their feasibility [Phase II].

RESULTS:

The following five tools were selected for the FASD screening toolkit: screening fatty acid ethyl esters in neonatal meconium, the modified Child Behaviour Checklist, Medicine Wheel tool, Asante Centre Probation Officer Tool, and maternal history of drinking and drug use.

CONCLUSIONS:

The toolkit for FASD screening aims at screening different populations, from the newborns to youth and at-risk mothers. It is anticipated that the toolkit will facilitate diagnosis of FASD.

PMID:
18840921
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center